← Eichor
Condition: Recurrent Bladder Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Recurrent Bladder Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Phase N/A · 6 location(s) · University of Washington · NCT07225127Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial
Phase N/A · 1 location(s) · OHSU Knight Cancer Institute · NCT07726602Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
Phase N/A · 1 location(s) · University of Zurich · NCT07494864Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer
Phase N/A · 1 location(s) · Jørgen Bjerggaard Jensen · NCT05337397Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Inte
Phase 3 · 1 location(s) · Fujian Medical University Union Hospital · NCT06441110Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT06878027Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation
Phase N/A · 2 location(s) · Jahn Ferenc South Pest Teaching Hospital · NCT06719232A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Phase 1/Phase 2 · 20 location(s) · SURGE Therapeutics · NCT05710848Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer
Phase 2 · 1 location(s) · Paul Toren · NCT07420517To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With H
Phase 1 · 2 location(s) · Shenzhen Xinhe Biomedical · NCT07594964Robotic Radical Cystectomy Outcomes
Phase N/A · 1 location(s) · University of Florence · NCT04900558Longitudinal Bladder Cancer Study for Tumour Recurrence
Phase N/A · 7 location(s) · Pacific Edge Limited · NCT05080998Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer
Phase N/A · 1 location(s) · Zhilong Dong · NCT07424560Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients
NA · 1 location(s) · National Taiwan University Hospital · NCT05739968Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
Phase 2 · 1 location(s) · University of California, Irvine · NCT06682728A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients
Phase 1 · 16 location(s) · OncoNano Medicine, Inc. · NCT06022029A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscl
Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT06733363PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bl
Phase 1 · 1 location(s) · University of California, Davis · NCT06173349Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
Phase 1/Phase 2 · 6 location(s) · Zhuhai Beihai Biotech Co., Ltd · NCT06732531Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma
Phase 2 · 1 location(s) · Nagoya University · NCT06983210Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Phase N/A · 1 location(s) · Zhiping Wang · NCT07589413Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06167356A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Phase 1/Phase 2 · 13 location(s) · Merck Sharp & Dohme LLC · NCT06637423A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Phase N/A · 3 location(s) · Early is Good Inc. · NCT05982561Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive B
Phase 3 · 6 location(s) · Verity Pharmaceuticals Inc. · NCT05037279Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring
Phase N/A · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07514897A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Mi
Phase N/A · 1 location(s) · Peking University First Hospital · NCT06991868AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
Phase N/A · 44 location(s) · Association Francaise d'Urologie · NCT05002556Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer
Phase 4 · 8 location(s) · Jakob Kristian Jakobsen · NCT06781879
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.